Category: The Evidence
For a well-nourished adult, the largest multivitamin trials mostly find nothing for heart disease or cancer. One recent, well-designed exception stands out: a modest but real memory signal in older adults. We grade both sides honestly.
Category: Research Reviews | Reading time: ~12 min | Level: Beginner
Roughly one in three adults in the United States takes a multivitamin on a given day, which makes it one of the most quietly normalised health habits there is: cheaper than therapy, easier than a diet overhaul, small enough to swallow without thinking. Nobody debates it the way they debate a new diet trend. It simply sits there, next to the toothbrush, doing its presumed job.
The trouble is that "presumed job" is doing a great deal of unexamined work in that sentence. Ask most people what a daily multivitamin actually does for them and the answer tends to be vague: fills gaps, covers the bases, cheap insurance. Ask what evidence supports that, and the conversation usually stalls. This is not a category anyone examines closely, partly because it feels too basic to interrogate and partly because the honest answer turns out to be more complicated, and more interesting, than either the enthusiasts or the sceptics usually allow.
That is the gap this review is built to close. The large, well-conducted trials on multivitamins and disease prevention mostly return a disappointing verdict, and the government bodies that assess this evidence for a living say so plainly. But sitting inside that otherwise unremarkable literature is one recent, genuinely notable exception: a signal, replicated across two separate trials, that a daily multivitamin may modestly support memory in older adults. That finding deserves to be named honestly, without either burying it under the negative headline or inflating it into more than it currently is.
The short answer: for the outcomes people most often hope a multivitamin will affect, heart disease and cancer prevention, the evidence is weak. The US Preventive Services Task Force reviewed the literature in 2022 and concluded there was insufficient evidence to recommend multivitamins for preventing cardiovascular disease or cancer in generally healthy, non-pregnant adults [1]. A large trial in male physicians found a modest reduction in cancer but no effect on cardiovascular events, a split result that resists a simple yes or no [2][3]. Where the evidence gets genuinely more interesting is cognition: two recent, well-designed randomised trials in older adults, run under the COSMOS research programme, found that a daily multivitamin modestly improved memory and overall cognitive performance compared with placebo [4][5]. That is a real, recent, worth-naming signal, not a settled case. For a well-nourished adult, the fair overall grade is weak for disease prevention, intriguing but early for cognition in older age, and most solidly useful as a way to correct an actual, documented dietary gap.
A multivitamin, more precisely a multivitamin/mineral supplement or MVM, is a single product combining a broad range of vitamins and minerals, typically dosed at or near the recommended dietary allowance for each. The underlying logic is simple: modern diets, for various reasons of convenience, cost, or preference, sometimes fall short on one or more nutrients, and a broad-spectrum supplement is a low-effort way to close that gap without tracking individual foods.
The mechanism, where a genuine gap exists, is straightforward biochemistry: correcting a deficiency in a nutrient like vitamin D, B12, or iron allows the specific bodily processes that depend on it to function normally again, which is why supplementation clearly helps people with a documented deficiency. The open question this review addresses is different: what a multivitamin does for someone who does not have a clear, documented gap, which is the situation most daily users are actually in.
This is the question multivitamins are most often bought to answer, silently or explicitly, and it is where the evidence is weakest. The US Preventive Services Task Force, an independent panel that reviews preventive health evidence for a living, issued a formal recommendation statement in 2022 concluding that current evidence is insufficient to assess the balance of benefits and harms of multivitamin or most single and paired nutrient supplements for preventing cardiovascular disease or cancer in generally healthy, non-pregnant adults. The same statement went further for two specific nutrients, advising against beta-carotene and vitamin E supplementation for this purpose, based on evidence of harm or lack of benefit [1].
The most detailed single data point behind this caution comes from the Physicians' Health Study II, a large randomised controlled trial that followed around 14,600 male physicians for over a decade. Its results are worth reading in full rather than as a single headline, because they split. The cancer analysis found a statistically significant, though modest, reduction in total cancer incidence in the group taking a daily multivitamin compared with placebo [2]. The cardiovascular analysis, published the same year from the same trial, found no reduction in major cardiovascular events, including heart attack, stroke, and cardiovascular death [3]. Put plainly: the same multivitamin, in the same people, over the same years, did one modest thing and did not do another. That is a genuinely useful result, because it resists being flattened into either "multivitamins work" or "multivitamins are useless." They appear to do a little, for one outcome, in one large trial, and nothing measurable for another.
The USPSTF's broader review, looking across the available trials rather than any single one, is why the overall verdict for disease prevention still lands on insufficient evidence rather than a clear yes [1]. A single positive finding in one large trial is a data point, not a consensus, and the totality of the evidence has not cleared the bar for a general recommendation.
This is the part of the multivitamin story that has genuinely moved in the last few years, and it is worth understanding on its own terms rather than folding it into the disease-prevention conversation. COSMOS, short for the COcoa Supplement and Multivitamin Outcomes Study, is a large research programme in older adults that has produced two separate, peer-reviewed findings specifically on cognition.
COSMOS-Mind, published in 2022 in Alzheimer's & Dementia, followed participants over three years and found that those randomised to a daily multivitamin showed improved global cognition compared with those on placebo, with the estimated effect roughly equivalent to slowing age-related cognitive decline by a small but measurable margin [4]. COSMOS-Web, published in 2023 in the American Journal of Clinical Nutrition, used a different, web-based cognitive testing approach in a separate, larger sample and specifically found an improvement in memory, particularly immediate recall, in the multivitamin group versus placebo [5].
What makes this worth taking seriously, rather than filing alongside the many single small studies that never replicate, is precisely that: two separate trials, from the same overall research programme, using different testing methods, both pointed in the same direction on cognition. That is a meaningfully stronger pattern than most individual supplement findings receive.
Genuinely interesting, yes. Settled, no. Three caveats matter here, and an honest review states them alongside the finding rather than after it.
First, the effect sizes reported in both trials are modest, describing a measurable but not dramatic average difference between groups, not a return to youthful memory function. Second, both trials were conducted specifically in older adults, so the finding does not currently extend to claims about cognition in younger or middle-aged people, who were not the population studied. Third, and this is standard, appropriate scientific caution rather than a hidden flaw, researchers involved in this line of work have themselves called for further replication before treating a multivitamin as an established cognitive intervention. Two consistent trials from one programme is a strong start. It is not yet the same as a large, independent, multi-institution confirmation over a longer follow-up period.
The honest framing: if you are an older adult, this is a real, recent signal that a daily multivitamin might offer a modest cognitive benefit alongside its established role in covering nutrient gaps, reasonable to weigh as a mild upside to a low-risk daily habit. It is not a basis for a confident claim that multivitamins protect memory, and marketing it that way overstates two good trials into more certainty than the researchers themselves claim.
Step back from both findings and a consistent, more useful picture emerges. The NIH Office of Dietary Supplements, which maintains the standard reference fact sheet on this category, is direct on this point: most people can get the nutrients they need from food, and multivitamins are not a shortcut to health for someone who is already well nourished [6]. Where the same fact sheet is more encouraging is for specific groups with a real, elevated need: people with restrictive diets, whether by choice, allergy, or a condition that limits food variety; older adults, who commonly absorb certain nutrients, particularly B12, less efficiently and may eat less overall; anyone recovering from illness, surgery, or with a condition affecting nutrient absorption; and people who are pregnant or planning a pregnancy, for whom folic acid specifically has strong, separate evidence for preventing neural tube defects [6].
That is a different, more precise case for multivitamins than "insurance for everyone." It is insurance specifically for people with a plausible, real gap, and a much weaker case for someone already eating a varied, adequate diet, for whom the trial evidence simply has not shown much to gain on the outcomes that matter most.
If you are generally healthy, eat a varied diet, and are taking a multivitamin hoping it meaningfully lowers your risk of heart disease or cancer, the evidence does not support that expectation, and it is worth being honest with yourself about that rather than treating the habit as a health strategy. If you are older, the COSMOS findings are a reasonable, evidence-based reason to view a daily multivitamin as a plausible small support for memory, worth discussing with whoever manages your care, alongside its established role covering nutrient gaps that become more common with age.
If you suspect you have an actual gap, restrictive eating, limited food variety, a medical condition affecting absorption, or you are planning a pregnancy, that is where the case for a multivitamin is genuinely strongest, and it is worth confirming the specific gap where possible, through diet review or blood testing, rather than assuming a general multivitamin covers it perfectly. And in every case, a multivitamin is a supplement to food, not a substitute for it. No combination of tablets replicates the fibre, protein, and full nutrient package of an actual varied diet.
Multivitamins at standard, RDA-range doses are generally well tolerated by most adults, with mild gastrointestinal upset being the most commonly reported issue. Two safety points are worth naming specifically rather than assuming "multivitamin" means uniformly low risk. High-dose fat-soluble vitamins, particularly A, D, E and K, can accumulate in the body over time in a way that water-soluble vitamins do not, so checking the specific doses in a product against established upper intake levels matters more than checking the front-of-pack claims. Iron-containing multivitamins should be used cautiously, and generally under guidance, by anyone with a condition involving iron overload, and are not automatically appropriate for men or postmenopausal women without a documented need, since iron accumulates rather than being readily excreted.
Pregnant, breastfeeding, or on medication? Check with a healthcare professional first. This matters specifically for multivitamins because dosing needs change substantially in pregnancy, certain vitamins carry their own upper limits and interaction profiles with prescription medication, and a general-purpose product is not automatically formulated for a specific medical situation.
We think the honest version of this story serves you better than the vague reassurance printed on most multivitamin packaging. A daily multivitamin is not shown to meaningfully lower your risk of heart disease or cancer if you are already well nourished, and it is worth knowing that plainly rather than assuming otherwise. Where the evidence has genuinely moved, the COSMOS memory findings in older adults, we think that deserves to be named specifically and precisely, not stretched into a broader claim it does not support.
If you are trying to work out whether you have an actual nutrient gap worth addressing rather than guessing with a general multivitamin, our vitamin D and B12 guides in the Remedy Library walk through the specific groups most likely to be short and what a targeted approach looks like. And if you want to talk through your own situation, medication list, or age-related question about the COSMOS findings, Remy can help you weigh the evidence against your specific circumstances rather than a generic label claim.
A multivitamin is not nothing, and it is not a health transformation in a tablet either. It is, honestly, a small, generally low-risk hedge: modest insurance against a gap you may or may not have, with one recent, real, and appropriately modest reason for older adults specifically to pay it a little more attention than the rest of the evidence would otherwise suggest.
1. US Preventive Services Task Force. Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Recommendation Statement. JAMA. 2022. Government recommendation statement concluding insufficient evidence exists that multivitamin or most single and paired nutrient supplements prevent cardiovascular disease or cancer in generally healthy, non-pregnant adults, and specifically advising against beta-carotene and vitamin E supplementation for this purpose. 2. Gaziano JM, Sesso HD, Christen WG, et al. Multivitamins in the Prevention of Cancer in Men: The Physicians' Health Study II Randomized Controlled Trial. JAMA. 2012;308(18):1871-1880. PMID 23162860. Large RCT in around 14,600 male physicians finding a statistically significant, modest reduction in total cancer incidence in the multivitamin group versus placebo. 3. Sesso HD, Christen WG, Bubes V, et al. Multivitamins in the Prevention of Cardiovascular Disease in Men: The Physicians' Health Study II Randomized Controlled Trial. JAMA. 2012;308(17):1751-1760. PMID 23117775. Same overall trial population, finding no significant reduction in major cardiovascular events with a daily multivitamin versus placebo. 4. Baker LD, Manson JE, Rapp SR, et al. Effects of cocoa extract and a multivitamin on cognitive function: a randomized clinical trial (COSMOS-Mind). Alzheimer's & Dementia. 2022. PMID 36102337. RCT in older adults finding improved global cognition over three years in the daily multivitamin group versus placebo. 5. Yeung LK, Alschuler DM, Wall M, et al. Multivitamin supplementation improves memory in older adults: a randomized clinical trial (COSMOS-Web). American Journal of Clinical Nutrition. 2023;118(1):273-282. PMID 37244291. RCT in older adults finding improved memory, particularly immediate recall, in the daily multivitamin group versus placebo, using web-based cognitive testing. 6. NIH Office of Dietary Supplements. Multivitamin/Mineral Supplements Fact Sheet. 2023. Government fact sheet stating most people can meet nutrient needs through food, and framing multivitamins as most useful for people with documented dietary gaps or increased nutrient needs.
For a well-nourished adult without a specific deficiency, the honest answer is not much, for the outcomes people usually hope for. The US Preventive Services Task Force concluded in 2022 there is insufficient evidence that multivitamins prevent cardiovascular disease or cancer in generally healthy adults. A large trial in male physicians found a modest reduction in cancer but no effect on heart disease. The one recent, genuinely interesting signal is for memory in older adults, found in the COSMOS trials, which is a narrower and more specific claim than "multivitamins are good for you."
The evidence does not support relying on one for that purpose. The Physicians' Health Study II, a large randomised trial in around 14,600 male physicians, found a statistically significant but modest reduction in total cancer incidence with a daily multivitamin, but the same trial found no reduction in major cardiovascular events. The USPSTF's 2022 review concluded the overall evidence across supplements, including multivitamins, was insufficient to recommend them for preventing either condition in generally healthy adults.
COSMOS is a large randomised trial programme in older adults that has produced two of the more interesting recent multivitamin findings. COSMOS-Mind, published in 2022, found that a daily multivitamin improved global cognition over three years compared with placebo. COSMOS-Web, published in 2023, found a specific improvement in memory, particularly immediate recall, versus placebo. Both are genuine, peer-reviewed findings in older adults, though the effect sizes are modest and researchers have called for replication before treating this as settled.
The COSMOS findings are a real, recent signal worth knowing about, specifically in older adults, but they describe a modest average improvement in a trial setting, not a guaranteed personal benefit, and they need replication in further trials before the case is considered strong. It is reasonable for an older adult to view this as a mild, plausible upside to a low-risk daily supplement, not as a proven memory treatment.
People with a documented or likely dietary gap: restrictive eaters, older adults with reduced absorption or appetite, anyone recovering from illness or surgery, and women planning a pregnancy who need folic acid specifically. The NIH Office of Dietary Supplements is explicit that most people can get the nutrients they need from food, and frames multivitamins as most useful for filling a real, specific gap rather than as a general-purpose health upgrade.
The trial evidence does not show much benefit for hard health outcomes in people who are already well nourished. It is unlikely to cause harm at standard doses, and the COSMOS cognitive signal applies broadly to older adults regardless of diet quality, but for a younger, well-nourished adult, the honest expectation should be low for disease prevention and modest at best elsewhere.
A multivitamin combines many vitamins and minerals at generally modest doses, aimed at covering broad dietary gaps. A single-nutrient supplement, such as vitamin D or iron alone, targets one specific, often higher, dose, usually because a blood test or clinical picture has identified a particular deficiency. The USPSTF specifically advised against single-nutrient beta-carotene and vitamin E supplements for disease prevention, a caution distinct from, and stronger than, its multivitamin conclusion.
The Physicians' Health Study II measured several different outcomes in the same trial, and they did not all move together. Cancer and cardiovascular disease have different biological drivers, and a multivitamin's broad, modest nutrient support does not need to affect both equally, or at all. This is a common and honest pattern in nutrition trials: a single intervention rarely produces a uniform effect across every outcome measured, which is exactly why summarising a trial as one word, working or not working, tends to mislead.
It should update your view without settling it. Two separate, well-designed randomised trials from the same research programme finding a consistent direction of effect on memory and cognition is more than a single small study, and it is a genuinely more encouraging signal than most of the disease-prevention literature. But the effect sizes reported are modest, the trials were conducted in specific older-adult populations, and researchers themselves have called for replication. Reasonable interest, not certainty, is the right response.
Based on the current evidence, the expected benefit is small. The disease-prevention trials mostly return null results in well-nourished adults, and the COSMOS cognitive findings were conducted in older adults, so they do not directly speak to your age group. A multivitamin is unlikely to hurt at standard doses, but the evidence does not support expecting a meaningful health effect either, and the money and effort probably matter more spent elsewhere, such as on the dietary gaps you might actually have.